Advertisements

Mepha-Gasec

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Mepha-Gasec

Quick Facts

Property Description
Active ingredient Omeprazole
Form Oral Gastro-resistant Capsule
Pharmacological class Proton Pump Inhibitor (PPI)
General purpose Suppression of gastric acid secretion
Origin Synthetic compound

What Type of Medicine is Mepha-Gasec? (Identity and Classification)

Mepha-Gasec is a synthetic pharmaceutical preparation containing the single active ingredient Omeprazole. This compound belongs to the Proton Pump Inhibitor (PPI) pharmacological class, a group designed specifically to manage conditions relating to stomach acid production. Omeprazole is chemically classified as a substituted benzimidazole derivative. As a PPI, Mepha-Gasec is used for the sustained control of gastric acid levels, offering a method for the suppression of acid secretion.


Composition and Drug Form (Delivery System)

Mepha-Gasec is supplied as an oral gastro-resistant capsule, designed to be swallowed whole. This dosage form is utilized because Omeprazole is acid-labile, meaning it is degraded by stomach acid, which would reduce its effectiveness. The enteric coating protects the active ingredient as it passes through the stomach, allowing it to reach the small intestine for systemic absorption. This specialized design ensures the drug’s intended bioavailability and systemic action.


What is the General Purpose of Mepha-Gasec? (High-Level Therapeutic Goal)

The general purpose of Mepha-Gasec is the suppression of gastric acid secretion. This is achieved by targeting and inhibiting the H^+K^+-ATPase enzyme, or proton pump, located in the stomach lining. By inhibiting the operation of this pump, the medication reduces the overall acid load in the stomach. This action supports its role as an agent for relieving discomfort and assisting the natural healing of tissues affected by excess or refluxed stomach acid, such as in instances of frequent heartburn.

Regulatory References

  1. Omeprazole: MedlinePlus Drug Information
Advertisements

What side effects are possible with Mepha-Gasec?

Possible side effects and safety information

Mepha-Gasec (omeprazole) has a safety profile established through official regulatory review, which classifies potential adverse reactions based on frequency and the body system affected. These classifications are used to formally communicate risks to patients and healthcare providers.


Adverse Reaction Classifications

Official labels group adverse effects into frequency tiers, reflecting their documented occurrence:

  • Common Reactions: Reactions reported in a significant number of patients include headache and effects affecting the Gastrointestinal System, such as abdominal pain, diarrhea, flatulence, nausea, and vomiting.
  • Uncommon Reactions: Less frequent reactions may involve the Nervous System (e.g., dizziness, insomnia, somnolence) and Skin (e.g., rash, pruritus).

Adverse reactions are also classified by the System-Organ Classes involved, including Hepatobiliary Disorders (e.g., increased liver enzymes) and Psychiatric Disorders.


Serious Adverse Reactions and Safety Patterns

Official documentation highlights rare but clinically significant reactions, such as severe hypersensitivity reactions (including anaphylactic shock and angioedema), severe cutaneous reactions (like Stevens-Johnson syndrome), and rare reports of severe blood disorders (e.g., agranulocytosis) or acute interstitial nephritis.

Certain safety considerations are officially linked to duration of use. Long-term daily use (typically one year or more) may be associated with an increased risk of bone fractures and micronutrient deficiencies, such as Vitamin B-12 deficiency or hypomagnesemia. Furthermore, the medicine is contraindicated in patients with a known hypersensitivity to omeprazole or other related compounds.

Advertisements

Overdose and Emergency Response

The official regulatory documentation for omeprazole states that overdose is typically described as benign and uncomplicated, even with reported single doses up to 400 mg. However, all suspected overdose situations require immediate professional assessment.

Documented Overdose Manifestations

Overdose manifestations listed in prescribing information often involve the gastrointestinal system and central nervous system. Common symptoms documented include nausea, vomiting, abdominal pain, and diarrhea. Central nervous system effects may also occur, such as headache, somnolence (drowsiness), dizziness, and confusion. More severe psychiatric manifestations, including agitation, depression, and hallucinations, have been reported in cases of high exposure.

Emergency Actions and Required Management

The government-approved patient information mandates that you seek immediate medical attention for any suspected overdose. Emergency services must be contacted immediately if the affected individual has collapsed, had a seizure, is experiencing trouble breathing, or cannot be awakened.

No specific antidote is known for omeprazole overdose. Therefore, clinical management is defined as strictly symptomatic and supportive treatment. This may include procedures such as gastric lavage or the administration of activated charcoal, as determined necessary by the attending healthcare professional.

Advertisements

Therapeutic Uses of Mepha-Gasec

What Mepha-Gasec Treats: Main Uses and Benefits

Mepha-Gasec (omeprazole) is used for managing symptoms related to heightened physiological activity caused by excess stomach acid. It is commonly applied across domains where additional symptomatic support is needed for conditions associated with peptic ulcers (gastric and duodenal), reflux oesophagitis, and symptomatic gastro-oesophageal reflux disease (GORD).

The medication is considered relevant in clinical settings that involve acute or unstable symptom patterns, often used when symptoms intensify and supportive relief is needed. This includes applications in chronic reflux conditions such as Zollinger-Ellison syndrome.

The medicine may assist with addressing symptom clusters that become intense or disruptive, supporting the patient during difficult episodes by easing distress. “It may assist with maintaining a sense of stability when symptoms are more noticeable.”


Quick Fact: Supports Relief for Burning and Discomfort

Advertisements

Eligibility and Restrictions for Use

Who can and cannot use Mepha-Gasec? — Official Regulatory Information

The eligibility for Mepha-Gasec (Omeprazole) is strictly defined by government regulatory agencies, establishing both absolute contraindications and population-specific restrictions.


Contraindicated Populations

Mepha-Gasec must not be used by patients with a known hypersensitivity to the active ingredient, any substituted benzimidazoles, or any component of the formulation. Use is also formally contraindicated in patients who are concurrently receiving the antiretroviral agents nelfinavir or rilpivirine.


Population and Condition-Based Restrictions

Restriction Category Official Regulatory Status
Age (Pediatric) Use is generally restricted and not established in infants under one month of age. Specific age-based approval exists only for defined pediatric indications.
Hepatic Function Patients with severe hepatic impairment require caution and may be subject to a maximum daily dose restriction.
Pregnancy Use is permitted only if the benefit justifies the potential risk to the fetus.
Lactation Use is generally not recommended as Omeprazole is excreted into human milk.
Pre-Treatment For adults, the presence of 'alarm symptoms' (e.g., unexplained weight loss) requires the exclusion of malignancy before starting therapy.

These official statements define who is permitted, restricted, or prohibited from using the medicine, strictly adhering to regulatory labeling requirements.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

Mepha-Gasec (omeprazole) is associated with officially documented interaction patterns primarily due to two actions: the profound suppression of gastric acid secretion and the inhibition of the CYP2C19 enzyme in the liver.

Official Regulatory Restrictions

Co-administration is strictly contraindicated with the antiretroviral Nelfinavir. Use with Atazanavir and Rilpivirine is restricted as Omeprazole significantly reduces their plasma exposure. Due to the documented diminished anti-platelet activity via CYP2C19 inhibition, co-administration with Clopidogrel is generally avoided.

Exposure Modification

Omeprazole's pH effect causes a decrease in the systemic exposure of medicines requiring an acidic environment for absorption, including Ketoconazole, Itraconazole, and Iron Salts. Conversely, Omeprazole may increase the plasma concentrations of drugs such as Digoxin, Cilostazol, Saquinavir, and Tacrolimus, as stated in regulatory prescribing information. The herbal product St John's Wort is also documented to reduce Omeprazole plasma levels.

Procedural Constraints

Official labeling documents that Omeprazole use may interfere with certain diagnostic procedures. It can cause an increase in Chromogranin A (CgA) levels, which may affect the interpretation of tests for neuroendocrine tumors.

Advertisements

Mechanism of Action

The Mechanism of Action: Irreversible Proton Pump Inhibition

Mepha-Gasec (Omeprazole) functions as an acid-activated prodrug that is selectively accumulated within the highly acidic secretory canaliculi of the stomach's parietal cells. The acidic environment triggers a chemical rearrangement, converting the inactive compound into its active sulfenamide metabolite. This active form then establishes a stable, covalent disulfide bond with specific cysteine residues on the Gastric H^+/ K^+-ATPase enzyme (the proton pump).

This binding causes the irreversible inactivation of the enzyme, directly blocking the final step of the physiological process for acid secretion. Because the pump is disabled, the parietal cell must synthesize and insert new enzyme molecules into its membrane to restore function. The resulting physiological consequence is a prolonged and sustained elevation of stomach pH due to a significant decrease in the concentration of hydrochloric acid in the stomach lumen; the mechanism results in a lasting suppression of secretory activity.

Advertisements

Dosage and Administration Information

Official Administration Guidelines

Mepha-Gasec, containing the active ingredient Omeprazole, is administered via the oral route using a gastro-resistant capsule or tablet. Usage typically involves taking the dose once daily (OD), preferably in the morning, and before eating to ensure proper absorption.


Dosage and Frequency Principles

Standard adult dosage regimens for healing conditions like duodenal or gastric ulcers generally range from 20 mg to 40 mg once daily. For the treatment of Pathological Hypersecretory Conditions (e.g., Zollinger-Ellison Syndrome), the initial dose is typically 60 mg once daily. For the latter, any total daily dosage exceeding 80 mg is administered in divided doses (twice or three times daily) to maintain continuous acid suppression.


Preparation and Handling

The gastro-resistant formulation is protected by a specialized coating, which necessitates strict adherence to administration instructions. The capsule or tablet must be swallowed whole with liquid and must not be chewed, crushed, or split, as this would compromise the enteric coating. For patients who cannot swallow the intact dosage form, the capsule may be opened and the pellets mixed with a tablespoon of cool, soft applesauce or a slightly acidic liquid to be swallowed immediately, without chewing the pellets.


Course Duration and Adjustments

Usage is prescribed in defined courses; for example, short-term treatment for active ulcers typically lasts 4 to 8 weeks. In contrast, therapy for pathological hypersecretory conditions is generally considered long-term, continuing for as long as indicated. Guidance is also available for special populations: no dose adjustment is needed for patients with renal impairment, but a reduced daily dose of 10 mg to 20 mg may be appropriate for those with hepatic impairment. If a dose is missed, it should be taken as soon as remembered unless it is nearly time for the next scheduled dose, in which case the missed dose should be skipped; double doses are forbidden.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies


Efficacy in Symptom Management

Studies have evaluated patient outcomes in individuals with chronic pain conditions. Research examined whether the compound was associated with reduced pain scores over a four-week period. Initial clinical studies reported mixed or inconclusive findings regarding reduced pain scores.

Research has explored its use in both acute and chronic conditions. One study investigated the compound's effect in acute flare-ups over a 72-hour period.


Pharmacological Action and Delivery

Research evaluated potential mechanisms. Studies have been conducted on this compound.

Further studies investigated whether the combination is associated with altered absorption compared to the monotherapy formulation; research examined whether this was associated with a reduction in symptoms over a six-month trial.


Safety and Tolerability Profile

Clinical trials evaluated the compound's safety profile, focusing on common adverse events such as gastrointestinal distress and headache. Reports on tolerability were included in the reviewed study documents.

Clinical studies have examined potential interactions with Drug Z. In these studies, some participants exhibited higher plasma concentrations of the compound when co-administered with Drug Y. These interactions were documented by researchers in the study reports.

The available research evaluated this compound across several small-scale trials. The evidence available in the reviewed studies is limited.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Mepha-Gasec (FAQ)


Q: How quickly can I expect Mepha-Gasec to start working?

According to official product information, the initial effect of acid suppression typically begins within one hour after the dose. The maximum effect on acid secretion is generally observed about two hours after administration.


Q: How long does the effect of one Mepha-Gasec capsule last?

The medicine is an irreversible inhibitor, meaning its binding to the acid pump is lasting. Due to this sustained mechanism, regulatory documents indicate that the acid-suppressing effect of a single dose can persist for approximately 72 hours.


Q: What happens if I forget to take my Mepha-Gasec?

If a dose is missed, official patient instructions state that it should be taken as soon as it is remembered. However, if it is nearly time for your next scheduled dose, the instructions advise skipping the missed dose entirely. The documentation specifies that a double dose should not be taken to make up for a missed dose.


Q: Is it true that Mepha-Gasec can be prescribed for H. pylori infection?

Yes, official labeling documents confirm that the medicine is prescribed in combination with specific antibiotics. This combination regimen is used specifically for the eradication of the Helicobacter pylori bacterium, which can be a cause of ulcers.


Q: Why do some people take Mepha-Gasec before meals and others after?

The administration instructions in regulatory documents typically specify taking the dose before a meal. This timing is specified because the drug is an acid-sensitive compound, and taking it before eating is important for promoting its proper absorption and systemic action.


Q: Can Mepha-Gasec be used for general stomach discomfort?

The medicine is officially indicated for the profound suppression of gastric acid secretion. This action addresses the underlying cause of specific diagnosed conditions, such as frequent heartburn and the discomfort associated with gastroesophageal reflux disease (GERD).


Q: Is there a known association between Mepha-Gasec use and bone density?

Regulatory warnings indicate that long-term, high-dose use (typically one year or more) may be associated with an increased risk of bone fractures of the hip, wrist, or spine. The association is primarily noted by the increased risk of bone fractures.


Q: Is Mepha-Gasec considered safe for use during pregnancy?

Regulatory documents describe that use during pregnancy is permitted only when the benefit is judged to justify the potential risk to the fetus. This decision is based on a review of risk and necessity by a healthcare provider.


Q: What is the guidance on using Mepha-Gasec while breastfeeding?

Regulatory documentation generally advises against use during lactation. This is because official sources state that the active ingredient, omeprazole, is known to be excreted into human milk.


Q: Is Mepha-Gasec the same as other medicines with 'omeprazole'?

Under regulatory standards, generic medicines containing the active ingredient omeprazole must have the same active ingredient, strength, quality, and intended use as the original product. They are considered therapeutically equivalent by health authorities.


Q: What is the difference between Mepha-Gasec and brand-name versions?

Regulatory agencies require that generic and brand-name versions be therapeutically equivalent. Any differences are typically limited to the inactive ingredients (such as coloring agents or fillers) and often the cost.


Q: Why do people say Mepha-Gasec is used for heartburn?

The medicine's action to suppress acid secretion directly addresses the cause of heartburn. The active ingredient, omeprazole, is officially indicated as an over-the-counter treatment for the underlying cause of frequent heartburn.


Q: Can Mepha-Gasec be purchased over the counter in some places?

The active ingredient, omeprazole, is available in both prescription-only and lower-dose, non-prescription (OTC) forms in several global jurisdictions. The specific availability depends on local regulations.


Q: Are there any common interactions between Mepha-Gasec and dietary supplements?

Official regulatory documentation mentions the herbal product St John's Wort as a supplement that may interact with the medicine. This is noted because it may reduce the concentration of omeprazole in the body.


Q: Are there any specific food or drinks to avoid while using Mepha-Gasec?

Regulatory guidance generally states that a normal diet can be maintained while using this medicine. However, official information sometimes references alcohol, noting that it can stimulate stomach acid production and potentially counteract the medicine’s effect.


Q: Does Mepha-Gasec contain gluten or lactose?

The exact list of inactive ingredients, such as lactose or gluten, depends on the specific product's license and formulation (e.g., capsule or tablet). This precise composition detail is documented in the official Patient Information Leaflet (PIL) for the medicine.


Q: Can older adults generally use Mepha-Gasec?

Official safety information does not generally advise against use based on age alone. However, it specifically emphasizes that adults aged 50 and older who use the medicine long-term may have an increased risk of bone fracture, requiring caution.


Q: Is there any research on Mepha-Gasec for children?

Use in children is restricted, and specific age-based approval for the compound exists only for defined pediatric indications (such as GERD) that have been established through authorized clinical research.


Q: Has Mepha-Gasec been studied for long-term safety?

Yes, the safety of long-term use has been examined in observational studies. These findings have led regulatory bodies to issue safety warnings related to potential risks like bone fracture and specific nutrient deficiencies over prolonged periods.


Q: What is the significance of the dosage strengths available for Mepha-Gasec?

Different dosage strengths are officially prescribed to treat specific conditions that require varying levels of acid suppression. Examples include lower doses for frequent heartburn versus higher doses for pathological hypersecretory conditions.


Q: Is Mepha-Gasec often combined with antacids?

Regulatory guidance indicates that antacids may be taken alongside this medicine for short-term, immediate relief from breakthrough symptoms. This is because the full acid-suppressing effect of Mepha-Gasec takes several days to reach its plateau.


Q: Can Mepha-Gasec cause skin sensitivity to the sun?

Official regulatory documentation lists specific skin reactions, including a rash or skin lesions that may worsen when exposed to sunlight, as a rare potential adverse effect of the medicine.


Q: How does Mepha-Gasec's action differ from a simple antacid?

Antacids provide immediate relief by neutralizing the acid already present in the stomach. In contrast, Mepha-Gasec is a proton pump inhibitor that works over time by blocking the enzyme responsible for creating stomach acid.


Q: What is the scientific evidence concerning the use of Mepha-Gasec for reflux?

Regulatory documentation confirms that the compound is indicated for the treatment of conditions related to gastroesophageal reflux disease (GERD). Its use is supported by clinical studies that have examined its effectiveness in reducing reflux symptoms.


Q: Is Mepha-Gasec intended for use in the emergency relief of pain?

No. Due to its mechanism of action, which requires time to fully suppress acid secretion, the medicine is intended for sustained, long-term control rather than for immediate or emergency relief.


Q: Is it possible to become dependent on Mepha-Gasec?

Official information addresses a phenomenon known as rebound hyperacidity that can occur when the medicine is stopped. This temporary return of symptoms may be confused with dependence, but it is considered a rebound effect noted after discontinuation.


Q: Are there specific patient warnings about Mepha-Gasec and driving?

Regulatory patient information typically states that the medicine does not usually affect the ability to drive or operate machinery. However, patients should be aware of rare side effects, such as dizziness or blurred vision, which could temporarily impact these abilities.


Q: Why do some people need to take Mepha-Gasec for a long period?

The medicine is prescribed for long-term use for conditions that involve the chronic and excessive production of stomach acid. Examples include Pathological Hypersecretory Conditions, such as Zollinger-Ellison Syndrome, which require sustained acid control.


Q: What is the process for reporting a suspected side effect from Mepha-Gasec?

Regulatory bodies strongly recommend that suspected side effects be reported through the official national pharmacovigilance system. This is done through government-run programs, such as the MedWatch Program in the US or the Yellow Card Scheme in the UK.

Advertisements

How should Mepha-Gasec be stored and disposed of?

How to Store and Dispose of Mepha-Gasec (Omeprazole)

Mepha-Gasec must be stored according to strict regulatory requirements to maintain the stability of the Omeprazole capsules.

Storage Requirements

Storage Factor Official Requirement
Temperature Do not store above 25 C or 30 C (varies by license).
Protection Store in the original package to protect from moisture and light.
Child Safety Keep out of the sight and reach of children.
Stability If in an HDPE bottle, use within 100 days after first opening.

Disposal

Unused or expired Mepha-Gasec must be disposed of in accordance with local requirements. The medicine should not be thrown into household waste or wastewater to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Mepha-Gasec found in:

A-Z Index: